{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:14:35Z","timestamp":1791497675068,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11030-022-10527-0","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T09:02:36Z","timestamp":1663837356000},"page":"1735-1749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-2761","authenticated-orcid":false,"given":"Nebih","family":"Lolak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Akocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Durgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Esra","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Necip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"1","key":"10527_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jep.2006.04.010","volume":"108","author":"A Ferreira","year":"2006","unstructured":"Ferreira A, Proen\u00e7a C, Serralheiro M, Araujo M (2006) The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J Ethnopharmacol 108(1):31\u201337. https:\/\/doi.org\/10.1016\/j.jep.2006.04.010","journal-title":"J Ethnopharmacol"},{"issue":"2\u20133","key":"10527_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jep.2004.02.012","volume":"92","author":"M Heinrich","year":"2004","unstructured":"Heinrich M, Teoh HL (2004) Galanthamine from snowdrop\u2014the development of a modern drug against Alzheimer\u2019s disease from local Caucasian knowledge. J Ethnopharmacol 92(2\u20133):147\u2013162. https:\/\/doi.org\/10.1016\/j.jep.2004.02.012","journal-title":"J Ethnopharmacol"},{"key":"10527_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2019.1683584","author":"M I\u015f\u0131k","year":"2019","unstructured":"I\u015f\u0131k M, Beydemir \u015e (2019) AChE mRNA expression as a possible novel biomarker for the diagnosis of coronary artery disease and Alzheimer\u2019s disease, and its association with oxidative stress. Arch Physiol Biochem. https:\/\/doi.org\/10.1080\/13813455.2019.1683584","journal-title":"Arch Physiol Biochem"},{"key":"10527_CR4","first-page":"1","volume":"390","author":"D Voet","year":"1995","unstructured":"Voet D, Voet J, John W, Jhon S (1995) Serine proteases. Biochemistry 390:1\u20137","journal-title":"Biochemistry"},{"issue":"2","key":"10527_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/13880209.2011.596209","volume":"50","author":"L Tavares","year":"2012","unstructured":"Tavares L, Fortalezas S, Tyagi M, Barata D, Serra AT, Martins Duarte CM et al (2012) Bioactive compounds from endemic plants of Southwest Portugal: Inhibition of acetylcholinesterase and radical scavenging activities. Pharm Biol 50(2):239\u2013246. https:\/\/doi.org\/10.3109\/13880209.2011.596209","journal-title":"Pharm Biol"},{"issue":"13","key":"10527_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jama.1994.03510370037029","volume":"271","author":"MJ Knapp","year":"1994","unstructured":"Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI et al (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer\u2019s disease. JAMA 271(13):985\u2013991","journal-title":"JAMA"},{"issue":"2","key":"10527_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10527_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00702-004-0188-x","volume":"112","author":"G Stuchbury","year":"2005","unstructured":"Stuchbury G, M\u00fcnch G (2005) Alzheimer\u2019s associated inflammation, potential drug targets and future therapies. J Neural Transm 112(3):429\u2013453. https:\/\/doi.org\/10.1007\/s00702-004-0188-x","journal-title":"J Neural Transm"},{"issue":"9","key":"10527_CR9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s11064-019-02852-y","volume":"44","author":"M I\u015f\u0131k","year":"2019","unstructured":"I\u015f\u0131k M (2019) The binding mechanisms and inhibitory effect of intravenous anesthetics on AChE in vitro and in vivo: kinetic analysis and molecular docking. Neurochem Res 44(9):2147\u20132155. https:\/\/doi.org\/10.1007\/s11064-019-02852-y","journal-title":"Neurochem Res"},{"issue":"3\u20134","key":"10527_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00726-003-0048-2","volume":"25","author":"V Calabrese","year":"2003","unstructured":"Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Stella AG et al (2003) Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25(3\u20134):437\u2013444. https:\/\/doi.org\/10.1007\/s00726-003-0048-2","journal-title":"Amino Acids"},{"issue":"26","key":"10527_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neurobiolaging.2004.07.017","volume":"5","author":"GE Gibson","year":"2005","unstructured":"Gibson GE, Huang H-M (2005) Oxidative stress in Alzheimer\u2019s disease. Neurobiol Aging 5(26):575\u2013578. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.07.017","journal-title":"Neurobiol Aging"},{"key":"10527_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.01.003","author":"M I\u015f\u0131k","year":"2017","unstructured":"I\u015f\u0131k M, Beydemir \u015e, Y\u0131lmaz A, Naldan ME, Aslan HE, G\u00fcl\u00e7in \u0130 (2017) Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients. Biomed Pharmacotherapy. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.003","journal-title":"Biomed Pharmacotherapy"},{"issue":"3","key":"10527_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/13813455.2015.1026912","volume":"121","author":"M I\u015f\u0131k","year":"2015","unstructured":"I\u015f\u0131k M, Demir Y, K\u0131r\u0131c\u0131 M, Demir R, \u015eim\u015fek F, Beydemir \u015e (2015) Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs. Arch Physiol Biochem 121(3):97\u2013102. https:\/\/doi.org\/10.3109\/13813455.2015.1026912","journal-title":"Arch Physiol Biochem"},{"issue":"10","key":"10527_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/0960327110391686","volume":"30","author":"A Mossa","year":"2011","unstructured":"Mossa A, Nawwar G (2011) Free radical scavenging and antiacetylcholinesterase activities of Origanum majorana L. essential oil. Hum Experimental Toxicol 30(10):1501\u20131513. https:\/\/doi.org\/10.1177\/0960327110391686","journal-title":"Hum Experimental Toxicol"},{"key":"10527_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"2015","unstructured":"Halliwell B, Gutteridge JM (2015) Free radicals in biology and medicine. Oxford University Press, Oxford"},{"issue":"4","key":"10527_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3923\/ijp.2015.366.371","volume":"100","author":"H Tohma","year":"2015","unstructured":"Tohma H, Isik M, Korkmaz M, Bursal E, Gulcin I, Koksal E (2015) Determination of antioxidant properties of Gypsophila bitlisensis bark. Int J Pharmacol 100(4):366\u2013437. https:\/\/doi.org\/10.3923\/ijp.2015.366.371","journal-title":"Int J Pharmacol"},{"issue":"2","key":"10527_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7(2):168\u2013181. https:\/\/doi.org\/10.1038\/nrd2467","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10527_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1517\/14728222.2015.1067685","volume":"19","author":"C Capasso","year":"2015","unstructured":"Capasso C, Supuran CT (2015) Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 19(12):1689\u20131704. https:\/\/doi.org\/10.1517\/14728222.2015.1067685","journal-title":"Expert Opin Ther Targets"},{"issue":"14","key":"10527_CR19","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.bmcl.2011.05.071","volume":"21","author":"SB\u00d6 Sarikaya","year":"2011","unstructured":"Sarikaya SB\u00d6, Topal F, \u015eent\u00fcrk M, G\u00fcl\u00e7in I, Supuran CT (2011) In vitro inhibition of \u03b1-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 21(14):4259\u20134262. https:\/\/doi.org\/10.1016\/j.bmcl.2011.05.071","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10527_CR20","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112(8):4421\u20134468. https:\/\/doi.org\/10.1021\/cr200176r","journal-title":"Chem Rev"},{"issue":"7","key":"10527_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/13543776.2012.698264","volume":"22","author":"F Carta","year":"2012","unstructured":"Carta F, Scozzafava A, Supuran CT (2012) Sulfonamides: a patent review (2008\u20132012). Expert Opin Ther Pat 22(7):747\u2013758. https:\/\/doi.org\/10.1517\/13543776.2012.698264","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"10527_CR22","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","volume":"25","author":"F Carta","year":"2017","unstructured":"Carta F, Vullo D, Osman SM, AlOthman Z, Supuran CT (2017) Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Bioorg Med Chem 25(9):2569\u20132576. https:\/\/doi.org\/10.1016\/j.bmc.2017.03.027","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10527_CR23","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1021\/acs.jmedchem.6b00492","volume":"59","author":"S Akocak","year":"2016","unstructured":"Akocak S, Alam MR, Shabana AM, Sanku RKK, Vullo D, Thompson H et al (2016) PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas. J Med Chem 59(10):5077\u20135088. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00492","journal-title":"J Med Chem"},{"issue":"12","key":"10527_CR24","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","volume":"25","author":"S Akocak","year":"2017","unstructured":"Akocak S, Lolak N, Nocentini A, Karakoc G, Tufan A, Supuran CT (2017) Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors. Bioorg Med Chem 25(12):3093\u20133097. https:\/\/doi.org\/10.1016\/j.bmc.2017.03.063","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10527_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/14756366.2019.1630616","volume":"34","author":"S Akocak","year":"2019","unstructured":"Akocak S, Lolak N, Bua S, Nocentini A, Supuran CT (2019) Activation of human \u03b1-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives. J Enzyme Inhib Med Chem 34(1):1193\u20131198. https:\/\/doi.org\/10.1080\/14756366.2019.1630616","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10527_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105473","author":"G Yapar","year":"2021","unstructured":"Yapar G, Duran HE, Lolak N, Akocak S, T\u00fcrke\u015f C, Durgun M et al (2021) Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105473","journal-title":"Bioorg Chem"},{"issue":"3","key":"10527_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000282","volume":"354","author":"M Kalayc\u0131","year":"2021","unstructured":"Kalayc\u0131 M, T\u00fcrke\u015f C, Arslan M, Demir Y, Beydemir \u015e (2021) Novel benzoic acid derivatives: synthesis and biological evaluation as multi-target acetylcholinesterase and carbonic anhydrase inhibitors. Arch Pharm (Weinheim, Ger) 354(3):e2000282. https:\/\/doi.org\/10.1002\/ardp.202000282","journal-title":"Arch Pharm (Weinheim, Ger)"},{"issue":"5","key":"10527_CR28","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1080\/07391102.2020.1736631","volume":"39","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes. J Biomol Struct Dyn 39(5):1672\u20131680. https:\/\/doi.org\/10.1080\/07391102.2020.1736631","journal-title":"J Biomol Struct Dyn"},{"issue":"45","key":"10527_CR29","doi-asserted-by":"publisher","first-page":"13347","DOI":"10.1002\/slct.201903458","volume":"4","author":"S G\u00fcndo\u011fdu","year":"2019","unstructured":"G\u00fcndo\u011fdu S, T\u00fcrke\u015f C, Arslan M, Demir Y, Beydemir \u015e (2019) New isoindole-1, 3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluation. ChemistrySelect 4(45):13347\u201313355. https:\/\/doi.org\/10.1002\/slct.201903458","journal-title":"ChemistrySelect"},{"issue":"6","key":"10527_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201900383","volume":"353","author":"Q Istrefi","year":"2020","unstructured":"Istrefi Q, T\u00fcrke\u015f C, Arslan M, Demir Y, Nixha AR, Beydemir \u015e et al (2020) Sulfonamides incorporating ketene N, S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors. Arch Pharm (Weinheim, Ger) 353(6):e1900383. https:\/\/doi.org\/10.1002\/ardp.201900383","journal-title":"Arch Pharm (Weinheim, Ger)"},{"issue":"12","key":"10527_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202100294","volume":"354","author":"B Sever","year":"2021","unstructured":"Sever B, T\u00fcrke\u015f C, Alt\u0131ntop MD, Demir Y, \u00c7ift\u00e7i GA, Beydemir \u015e (2021) Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Arch Pharm (Weinheim, Ger) 354(12):e2100294. https:\/\/doi.org\/10.1002\/ardp.202100294","journal-title":"Arch Pharm (Weinheim, Ger)"},{"issue":"6","key":"10527_CR32","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1002\/slct.202102082","volume":"29","author":"\u00dc Ya\u015far","year":"2021","unstructured":"Ya\u015far \u00dc, G\u00f6n\u00fcl \u0130, T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Transition\u2013metal complexes of bidentate schiff-base ligands: in vitro and in silico evaluation as non-classical carbonic anhydrase and potential acetylcholinesterase inhibitors. ChemistrySelect 29(6):7278\u20137284. https:\/\/doi.org\/10.1002\/slct.202102082","journal-title":"ChemistrySelect"},{"key":"10527_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103897","author":"N Lolak","year":"2020","unstructured":"Lolak N, Akocak S, T\u00fcrke\u015f C, Taslimi P, I\u015f\u0131k M, Beydemir \u015e et al (2020) Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1, 3, 5-triazine structural motifs. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103897","journal-title":"Bioorg Chem"},{"issue":"2","key":"10527_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10527_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202000958","volume":"18","author":"S Akocak","year":"2021","unstructured":"Akocak S, Taslimi P, Lolak N, I\u015f\u0131k M, Durgun M, Budak Y et al (2021) Synthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as \u03b1-glycosidase and cholinesterase inhibitors. Chem Biodivers 18(4):e2000958. https:\/\/doi.org\/10.1002\/cbdv.202000958","journal-title":"Chem Biodivers"},{"issue":"15","key":"10527_CR36","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1080\/07391102.2020.1790422","volume":"39","author":"P Taslimi","year":"2021","unstructured":"Taslimi P, I\u015f\u0131k M, T\u00fcrkan F, Durgun M, T\u00fcrke\u015f C, G\u00fcl\u00e7in \u0130 et al (2021) Benzenesulfonamide derivatives as potent acetylcholinesterase, \u03b1-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies. J Biomol Struct Dyn 39(15):5449\u20135460. https:\/\/doi.org\/10.1080\/07391102.2020.1790422","journal-title":"J Biomol Struct Dyn"},{"key":"10527_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1916599","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Akocak S, I\u015f\u0131k M, Lolak N, Taslimi P, Durgun M et al (2021) Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1916599","journal-title":"J Biomol Struct Dyn"},{"key":"10527_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/bab.2284","author":"B \u00c7al\u0131\u015fkan","year":"2021","unstructured":"\u00c7al\u0131\u015fkan B, Demir Y, T\u00fcrke\u015f C (2021) Ophthalmic Drugs: In vitro paraoxonase 1 inhibition and molecular docking studies. Biotechnol Appl Biochem. https:\/\/doi.org\/10.1002\/bab.2284","journal-title":"Biotechnol Appl Biochem"},{"issue":"3","key":"10527_CR39","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ddr.21887","volume":"83","author":"FS Tokal\u0131","year":"2022","unstructured":"Tokal\u0131 FS, Demir Y, Demircio\u011flu \u0130H, T\u00fcrke\u015f C, Kalay E, \u015eendil K et al (2022) Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4 (3H)-one derivatives as potential aldose reductase inhibitors. Drug Dev Res 83(3):586\u2013604. https:\/\/doi.org\/10.1002\/ddr.21887","journal-title":"Drug Dev Res"},{"issue":"43","key":"10527_CR40","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1002\/slct.202103197","volume":"6","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2021) Infection medications: assessment in-vitro glutathione S-transferase inhibition and molecular docking study. ChemistrySelect 6(43):11915\u201311924. https:\/\/doi.org\/10.1002\/slct.202103197","journal-title":"ChemistrySelect"},{"key":"10527_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23180","author":"IN Korkmaz","year":"2022","unstructured":"Korkmaz IN, T\u00fcrke\u015f C, Demir Y, \u00d6ztekin A, \u00d6zdemir H, Beydemir \u015e (2022) Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.23180","journal-title":"J Biochem Mol Toxicol"},{"key":"10527_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23152","author":"IN Korkmaz","year":"2022","unstructured":"Korkmaz IN, T\u00fcrke\u015f C, Demir Y, \u00d6zdemir H, Beydemir \u015e (2022) Methyl benzoate derivatives: in vitro paraoxonase 1 inhibition and in silico studies. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.23152","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10527_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12010-019-03009-x","volume":"189","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2019) Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity. Appl Biochem Biotechnol 189(1):318\u2013329. https:\/\/doi.org\/10.1007\/s12010-019-03009-x","journal-title":"Appl Biochem Biotechnol"},{"issue":"40","key":"10527_CR44","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1002\/slct.202103100","volume":"6","author":"C T\u00fcrke\u015f","year":"2021","unstructured":"T\u00fcrke\u015f C, Kesebir \u00d6zt\u00fcrk A, Demir Y, K\u00fcfrevio\u011flu \u00d6\u0130, Beydemir \u015e (2021) Calcium channel blockers: the effect of glutathione S-transferase enzyme activity and molecular docking studies. ChemistrySelect 6(40):11137\u201311143. https:\/\/doi.org\/10.1002\/slct.202103100","journal-title":"ChemistrySelect"},{"issue":"4617","key":"10527_CR45","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/1811199a0","volume":"181","author":"MS Blois","year":"1958","unstructured":"Blois MS (1958) Antioxidant determinations by the use of a stable free radical. Nature 181(4617):1199\u20131200. https:\/\/doi.org\/10.1038\/1811199a0","journal-title":"Nature"},{"issue":"9\u201310","key":"10527_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","volume":"26","author":"R Re","year":"1999","unstructured":"Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med 26(9\u201310):1231\u20131237. https:\/\/doi.org\/10.1016\/S0891-5849(98)00315-3","journal-title":"Free Radical Biol Med"},{"issue":"33","key":"10527_CR47","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1002\/slct.201902424","volume":"4","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Beydemir \u015e, K\u00fcfrevio\u011flu \u00d6\u0130 (2019) In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect 4(33):9731\u20139736. https:\/\/doi.org\/10.1002\/slct.201902424","journal-title":"ChemistrySelect"},{"issue":"5","key":"10527_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/01480545.2019.1620266","volume":"44","author":"\u015e Beydemir","year":"2021","unstructured":"Beydemir \u015e, T\u00fcrke\u015f C, Yal\u00e7\u0131n A (2021) Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies. Drug Chem Toxicol 44(5):508\u2013517. https:\/\/doi.org\/10.1080\/01480545.2019.1620266","journal-title":"Drug Chem Toxicol"},{"issue":"9","key":"10527_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000102","volume":"353","author":"M I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k M, Akocak S, Lolak N, Taslimi P, T\u00fcrke\u015f C, G\u00fcl\u00e7in \u0130 et al (2020) Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives. Arch Pharm (Weinheim, Ger) 353(9):e2000102. https:\/\/doi.org\/10.1002\/ardp.202000102","journal-title":"Arch Pharm (Weinheim, Ger)"},{"issue":"14","key":"10527_CR50","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","volume":"61","author":"M Bozdag","year":"2018","unstructured":"Bozdag M, Carta F, Ceruso M, Ferraroni M, McDonald PC, Dedhar S et al (2018) Discovery of 4-hydroxy-3-(3-(phenylureido) benzenesulfonamides as SLC-0111 analogues for the treatment of hypoxic tumors overexpressing carbonic anhydrase IX. J Med Chem 61(14):6328\u20136338. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00770","journal-title":"J Med Chem"},{"key":"10527_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.11.073","author":"MR Buemi","year":"2019","unstructured":"Buemi MR, Di Fiore A, De Luca L, Angeli A, Mancuso F, Ferro S et al (2019) Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl) benzenesulfonamide moiety. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.073","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10527_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L et al (2013) Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl-and butyryl-cholinesterase. Biochem J 453(3):393\u2013399. https:\/\/doi.org\/10.1042\/BJ20130013","journal-title":"Biochem J"},{"issue":"1","key":"10527_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12010-019-03073-3","volume":"190","author":"C T\u00fcrke\u015f","year":"2020","unstructured":"T\u00fcrke\u015f C, Beydemir \u015e (2020) Inhibition of human serum paraoxonase-I with antimycotic drugs: in vitro and in silico studies. Appl Biochem Biotechnol 190(1):252\u2013269. https:\/\/doi.org\/10.1007\/s12010-019-03073-3","journal-title":"Appl Biochem Biotechnol"},{"key":"10527_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105009","author":"S Askin","year":"2021","unstructured":"Askin S, Tahtaci H, T\u00fcrke\u015f C, Demir Y, Ece A, \u00c7ift\u00e7i GA et al (2021) Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2, 1-b][1, 3, 4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105009","journal-title":"Bioorg Chem"},{"issue":"1","key":"10527_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/07391102.2020.1806927","volume":"40","author":"C T\u00fcrke\u015f","year":"2022","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e (2022) Some calcium-channel blockers: kinetic and in silico studies on paraoxonase-I. J Biomol Struct Dyn 40(1):77\u201385. https:\/\/doi.org\/10.1080\/07391102.2020.1806927","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"10527_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/0929866526666190226162225","volume":"26","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C (2019) Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: chemotherapeutic drugs. Protein Pept Lett 26(6):392\u2013402. https:\/\/doi.org\/10.2174\/0929866526666190226162225","journal-title":"Protein Pept Lett"},{"issue":"7","key":"10527_CR57","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1871520620666200218110645","volume":"20","author":"Y Demir","year":"2020","unstructured":"Demir Y, T\u00fcrke\u015f C, Beydemir \u015e (2020) Molecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-I. Anti-Cancer Agents Med Chem 20(7):887\u2013896. https:\/\/doi.org\/10.2174\/1871520620666200218110645","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"10527_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103004","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C, Arslan M, Demir Y, Cocaj L, Nixha AR, Beydemir \u015e (2019) Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103004","journal-title":"Bioorg Chem"},{"key":"10527_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.09.237","author":"M I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k M, Beydemir \u015e, Demir Y, Durgun M, T\u00fcrke\u015f C, Nas\u0131r A et al (2020) Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.237","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"10527_CR60","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/jphp.13141","volume":"71","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f C (2019) A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors. J Pharm Pharmacol 71(10):1553\u20131564. https:\/\/doi.org\/10.1111\/jphp.13141","journal-title":"J Pharm Pharmacol"},{"key":"10527_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2020.121542","author":"A Kilic","year":"2020","unstructured":"Kilic A, Beyazsakal L, I\u015f\u0131k M, T\u00fcrke\u015f C, Necip A, Tak\u0131m K et al (2020) Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: synthesis, spectroscopy and in vitro\/in silico biological studies. J Organomet Chem. https:\/\/doi.org\/10.1016\/j.jorganchem.2020.121542","journal-title":"J Organomet Chem"},{"issue":"7","key":"10527_CR62","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"issue":"7","key":"10527_CR63","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47(7):1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"10527_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.09.043","author":"B Sever","year":"2020","unstructured":"Sever B, T\u00fcrke\u015f C, Alt\u0131ntop MD, Demir Y, Beydemir \u015e (2020) Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.043","journal-title":"Int J Biol Macromol"},{"key":"10527_CR65","doi-asserted-by":"publisher","DOI":"10.1515\/chem-2021-0032","author":"B Sever","year":"2021","unstructured":"Sever B, Alt\u0131ntop MD, Demir Y, T\u00fcrke\u015f C, \u00d6zba\u015f K, \u00c7ift\u00e7i GA et al (2021) A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity. Open Chem. https:\/\/doi.org\/10.1515\/chem-2021-0032","journal-title":"Open Chem"},{"key":"10527_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1967195","author":"Y Demir","year":"2021","unstructured":"Demir Y, Ceylan H, T\u00fcrke\u015f C, Beydemir \u015e (2021) Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1967195","journal-title":"J Biomol Struct Dyn"},{"issue":"21","key":"10527_CR67","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49(21):6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"10527_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/JMR.2991","author":"C T\u00fcrke\u015f","year":"2022","unstructured":"T\u00fcrke\u015f C, Arslan M, Demir Y, \u00c7o\u00e7aj L, Nixha AR, Beydemir \u015e (2022) N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors. J Mol Recognit. https:\/\/doi.org\/10.1002\/JMR.2991","journal-title":"J Mol Recognit"},{"key":"10527_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202200132","author":"D Osmaniye","year":"2022","unstructured":"Osmaniye D, T\u00fcrke\u015f C, Demir Y, \u00d6zkay Y, Beydemir \u015e, Kaplanc\u0131kl\u0131 ZA (2022) Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrides as carbonic anhydrase inhibitors. Arch Pharm (Weinheim, Ger). https:\/\/doi.org\/10.1002\/ardp.202200132","journal-title":"Arch Pharm (Weinheim, Ger)"},{"key":"10527_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10422-8","author":"\u00d6 G\u00fcle\u00e7","year":"2022","unstructured":"G\u00fcle\u00e7 \u00d6, T\u00fcrke\u015f C, Arslan M, Demir Y, Yeni Y, Hac\u0131m\u00fcft\u00fco\u011flu A et al (2022) Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-022-10422-8","journal-title":"Mol Divers"},{"issue":"6","key":"10527_CR71","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"F Pacchiano","year":"2011","unstructured":"Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A et al (2011) Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 54(6):1896\u20131902. https:\/\/doi.org\/10.1021\/jm101541x","journal-title":"J Med Chem"},{"issue":"9","key":"10527_CR72","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","volume":"71","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364\u20133376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4261","journal-title":"Cancer Res"},{"issue":"6","key":"10527_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1517\/17460441.2015.1038235","volume":"10","author":"CT Supuran","year":"2015","unstructured":"Supuran CT, Winum J-Y (2015) Designing carbonic anhydrase inhibitors for the treatment of breast cancer. Expert Opin Drug Discov 10(6):591\u2013597. https:\/\/doi.org\/10.1517\/17460441.2015.1038235","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"10527_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","volume":"61","author":"U Kosak","year":"2018","unstructured":"Kosak U, Brus B, Knez D, Zakelj S, Trontelj J, Pislar A et al (2018) The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity. J Med Chem 61(1):119\u2013139. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01086","journal-title":"J Med Chem"},{"key":"10527_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2013.02.009","author":"MA Khanfar","year":"2013","unstructured":"Khanfar MA, AbuKhader MM, Alqtaishat S, Taha MO (2013) Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. J Mol Graph Model. https:\/\/doi.org\/10.1016\/j.jmgm.2013.02.009","journal-title":"J Mol Graph Model"},{"key":"10527_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2015.09.008","author":"S Riaz","year":"2015","unstructured":"Riaz S, Khan IU, Bajda M, Ashraf M, Shaukat A, Rehman TU et al (2015) Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer\u2019s disease: in vitro studies against yeast \u03b1-glucosidase, acetylcholinesterase and butyrylcholinesterase. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2015.09.008","journal-title":"Bioorg Chem"},{"issue":"14","key":"10527_CR77","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/BCJ20160115","volume":"473","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Structure and function of carbonic anhydrases. Biochem J 473(14):2023\u20132032. https:\/\/doi.org\/10.1042\/BCJ20160115","journal-title":"Biochem J"},{"issue":"10","key":"10527_CR78","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767\u2013777. https:\/\/doi.org\/10.1038\/nrd3554","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10527_CR79","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1517\/17460441.2013.795145","volume":"8","author":"G De Simone","year":"2013","unstructured":"De Simone G, Alterio V, Supuran CT (2013) Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 8(7):793\u2013810. https:\/\/doi.org\/10.1517\/17460441.2013.795145","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"10527_CR80","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","volume":"83","author":"TJ Littlejohns","year":"2014","unstructured":"Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH et al (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83(10):920\u2013928. https:\/\/doi.org\/10.1212\/WNL.0000000000000755","journal-title":"Neurology"},{"issue":"5","key":"10527_CR81","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1440-1819.2011.02253.x","volume":"65","author":"M Takeda","year":"2011","unstructured":"Takeda M, Tanaka T, Okochi M (2011) New drugs for Alzheimer\u2019s disease in Japan. Psychiatry Clin Neurosci 65(5):399\u2013404. https:\/\/doi.org\/10.1111\/j.1440-1819.2011.02253.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"10527_CR82","doi-asserted-by":"publisher","first-page":"2000375","DOI":"10.1002\/ardp.202000375","volume":"354","author":"M Tugrak","year":"2021","unstructured":"Tugrak M, Gul HI, Demir Y, Levent S, Gulcin I (2021) Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides. Arch Pharm (Weinheim, Ger) 354(4):2000375. https:\/\/doi.org\/10.1002\/ardp.202000375","journal-title":"Arch Pharm (Weinheim, Ger)"},{"key":"10527_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2018.06.004","author":"S Alyar","year":"2018","unstructured":"Alyar S, \u015een C, Alyar H, Adem \u015e, Kalkanci A, Ozdemir UO (2018) Synthesis, characterization, antimicrobial activity, carbonic anhydrase enzyme inhibitor effects, and computational studies on new Schiff bases of Sulfa drugs and their Pd(II), Cu(II) complexes. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2018.06.004","journal-title":"J Mol Struct"},{"issue":"8","key":"10527_CR84","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.arabjc.2015.05.020","volume":"12","author":"S Mert","year":"2019","unstructured":"Mert S, Al\u0131m Z, \u0130\u015fg\u00f6r MM, An\u0131l B, Kas\u0131mo\u011fullar\u0131 R, Beydemir \u015e (2019) Novel pyrazole-3, 4-dicarboxamides bearing biologically active sulfonamide moiety as potential carbonic anhydrase inhibitors. Arab J Chem 12(8):2740\u20132748. https:\/\/doi.org\/10.1016\/j.arabjc.2015.05.020","journal-title":"Arab J Chem"},{"issue":"7","key":"10527_CR85","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","volume":"20","author":"CA Rice-Evans","year":"1996","unstructured":"Rice-Evans CA, Miller NJ, Paganga G (1996) Structure\u2013antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med 20(7):933\u2013956. https:\/\/doi.org\/10.1016\/0891-5849(95)02227-9","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"10527_CR86","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/14756366.2020.1746784","volume":"35","author":"M Durgun","year":"2020","unstructured":"Durgun M, T\u00fcrke\u015f C, I\u015f\u0131k M, Demir Y, Sakl\u0131 A, Kuru A et al (2020) Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases. J Enzyme Inhib Med Chem 35(1):950\u2013962. https:\/\/doi.org\/10.1080\/14756366.2020.1746784","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10527-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T17:24:54Z","timestamp":1691688294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10527-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10527"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10527-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}